首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >Synthesis and evaluation of acetylcholinesterase inhibitory effects of 2-(2-(4-benzoylpiperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione derivatives with potential anti-Alzheimer activity
【24h】

Synthesis and evaluation of acetylcholinesterase inhibitory effects of 2-(2-(4-benzoylpiperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione derivatives with potential anti-Alzheimer activity

机译:具有潜在抗阿尔茨海默氏病活性的2-(2-(4-(4-苯甲酰基哌嗪-1-基)乙基)-1H-苯并[de]异喹啉-1,3(2H)-二酮衍生物的乙酰胆碱酯酶抑制作用的合成和评价

获取原文
           

摘要

Alzheimer’s disease (AD) is the most common form of dementia in elderly people. The disease is characterized as age-dependent chronic and neurodegenerative disorder. Cognitive decline is supposed to be related to the degeneration of cholinergic neurons in the affected brain structures. Design and development of novel acetylcholinesterase inhibitors is one of the interesting areas in medicinal chemistry. In the current project, a new series of naphthalimide-based anti-acetylcholinesterase were synthesized and their enzyme inhibitory potency was assessed using Ellman's protocol. Fortunately, the most of tested derivatives demonstrated favorable acetylcholinesterase activity. Amongst tested derivatives, compound 4k (3-OCH3) was the most active compounds in these series (IC50 = 0.26 μM).
机译:阿尔茨海默氏病(AD)是老年人中最常见的痴呆形式。该疾病的特征是年龄依赖性的慢性和神经退行性疾病。认知能力下降可能与受影响的大脑结构中胆碱能神经元的变性有关。新型乙酰胆碱酯酶抑制剂的设计和开发是药物化学中有趣的领域之一。在当前项目中,合成了一系列新的基于萘二甲酰亚胺的抗乙酰胆碱酯酶,并使用Ellman方案评估了其酶抑制能力。幸运的是,大多数测试的衍生物都显示出良好的乙酰胆碱酯酶活性。在测试的衍生物中,化合物4k(3-OCH3)是这些系列中活性最高的化合物(IC50 = 0.26μM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号